BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 18496518)

  • 1. Glucocorticoid receptor antagonism augments fluoxetine-induced downregulation of the 5-HT transporter.
    Johnson DA; Ingram CD; Grant EJ; Craighead M; Gartside SE
    Neuropsychopharmacology; 2009 Jan; 34(2):399-409. PubMed ID: 18496518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor antagonists hasten and augment neurochemical responses to a selective serotonin reuptake inhibitor antidepressant.
    Johnson DA; Grant EJ; Ingram CD; Gartside SE
    Biol Psychiatry; 2007 Dec; 62(11):1228-35. PubMed ID: 17651703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
    Freo U; Merico A; Ermani M; Ori C
    Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H; Wang W; Jiang Z; Shang J; Zhang L
    Arzneimittelforschung; 2010; 60(3):109-15. PubMed ID: 20422941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J; Sarkar J; Hiegel C; Uphouse L
    Horm Behav; 2010 Jul; 58(2):290-6. PubMed ID: 20223238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain.
    Castro M; Diaz A; del Olmo E; Pazos A
    Neuropharmacology; 2003 Jan; 44(1):93-101. PubMed ID: 12559126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality.
    Castro E; Díaz A; Rodriguez-Gaztelumendi A; Del Olmo E; Pazos A
    Neuropharmacology; 2008 Dec; 55(8):1391-6. PubMed ID: 18809415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
    Popova NK; Naumenko VS; Cybko AS; Bazovkina DV
    Neuroscience; 2010 Aug; 169(1):229-35. PubMed ID: 20423722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep brain stimulation and fluoxetine exert different long-term changes in the serotonergic system.
    Volle J; Bregman T; Scott B; Diwan M; Raymond R; Fletcher PJ; Nobrega JN; Hamani C
    Neuropharmacology; 2018 Jun; 135():63-72. PubMed ID: 29505786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic fluoxetine treatment in the presence and absence of (+/-)pindolol: a microdialysis study.
    Dawson LA; Nguyen HQ; Smith DI; Schechter LE
    Br J Pharmacol; 2000 Jun; 130(4):797-804. PubMed ID: 10864885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the antidepressant fluoxetine on the subcellular localization of 5-HT1A receptors and SERT.
    Descarries L; Riad M
    Philos Trans R Soc Lond B Biol Sci; 2012 Sep; 367(1601):2416-25. PubMed ID: 22826342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic effects of citalopram on 5-HT1A receptor-labeling by [18F]MPPF and -coupling to receptors-G proteins.
    Moulin-Sallanon M; Charnay Y; Ginovart N; Perret P; Lanfumey L; Hamon M; Hen R; Fagret D; Ibáñez V; Millet P
    Synapse; 2009 Feb; 63(2):106-16. PubMed ID: 19016488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan.
    Jacobsen JP; Nielsen EØ; Hummel R; Redrobe JP; Mirza N; Weikop P
    Psychopharmacology (Berl); 2008 Aug; 199(2):137-50. PubMed ID: 18496675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness.
    Naudon L; El Yacoubi M; Vaugeois JM; Leroux-Nicollet I; Costentin J
    Brain Res; 2002 May; 936(1-2):68-75. PubMed ID: 11988231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter.
    Fabre V; Beaufour C; Evrard A; Rioux A; Hanoun N; Lesch KP; Murphy DL; Lanfumey L; Hamon M; Martres MP
    Eur J Neurosci; 2000 Jul; 12(7):2299-310. PubMed ID: 10947809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.